Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders

It has become apparent that the molecular and biochemical integrity of interactive families, genera, and species of human gut microflora is critically linked to maintaining complex metabolic and behavioral processes mediated by peripheral organ systems and central nervous system neuronal groupings. Relatively recent studies have established intrinsic ratios of enterotypes contained within the human microbiome across demographic subpopulations and have empirically linked significant alterations in the expression of bacterial enterotypes with the initiation and persistence of several major metabolic and psychiatric disorders. Accordingly, the goal of our review is to highlight potential thematic/functional linkages of pathophysiological alterations in gut microbiota and bidirectional gut–brain signaling pathways with special emphasis on the potential roles of gut dysbiosis on the pathophysiology of psychiatric illnesses. We provide critical discussion of putative thematic linkages of Parkinson’s disease (PD) data sets to similar pathophysiological events as potential causative factors in the development and persistence of diverse psychiatric illnesses. Finally, we include a concise review of preclinical paradigms that involve immunologically–induced GI deficits and dysbiosis of maternal microflora that are functionally linked to impaired neurodevelopmental processes leading to affective behavioral syndromes in the offspring.

[1]  A. Kraneveld,et al.  Exploring Braak’s Hypothesis of Parkinson’s Disease , 2017, Front. Neurol..

[2]  Avijit Ray,et al.  Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis , 2015, Immunology.

[3]  A. Jačan,et al.  Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication , 2016, Brain, Behavior, and Immunity.

[4]  D. Devos,et al.  Colonic inflammation in Parkinson's disease , 2013, Neurobiology of Disease.

[5]  J. Cryan,et al.  Microbe-host interactions: Influence of the gut microbiota on the enteric nervous system. , 2016, Developmental biology.

[6]  L. Bodea,et al.  Neurodegeneration by Activation of the Microglial Complement–Phagosome Pathway , 2014, The Journal of Neuroscience.

[7]  R. Kream,et al.  Psychiatric Disorders Involving Mitochondrial Processes , 2015 .

[8]  E. Pekkonen,et al.  Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.

[9]  R. Kream,et al.  Antibiotics May Trigger Mitochondrial Dysfunction Inducing Psychiatric Disorders , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[10]  E. Noble,et al.  Gut to Brain Dysbiosis: Mechanisms Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment , 2017, Front. Behav. Neurosci..

[11]  Satinder K. Singh,et al.  Biophysical Approaches to the Study of LeuT, a Prokaryotic Homolog of Neurotransmitter Sodium Symporters. , 2015, Methods in enzymology.

[12]  R. Kream,et al.  Mitochondria, Microbiome and Their Potential Psychiatric Modulation , 2015 .

[13]  Gregor Bieri,et al.  Internalization, axonal transport and release of fibrillar forms of alpha-synuclein , 2018, Neurobiology of Disease.

[14]  P. Conti,et al.  Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. , 2015, Clinical therapeutics.

[15]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[16]  H. Savelkoul,et al.  Immune dysregulation in autism spectrum disorder , 2013, European Journal of Pediatrics.

[17]  B. Main,et al.  Microbial Immuno-Communication in Neurodegenerative Diseases , 2017, Front. Neurosci..

[18]  H. Braak,et al.  Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff , 2017, Journal of Parkinson's disease.

[19]  J. Eisen,et al.  The enteric nervous system promotes intestinal health by constraining microbiota composition , 2017, PLoS biology.

[20]  W. D. de Vos,et al.  Homeostasis of the gut barrier and potential biomarkers , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[21]  T. Dinan,et al.  A gut (microbiome) feeling about the brain , 2016, Current opinion in gastroenterology.

[22]  H. Forssberg,et al.  Normal gut microbiota modulates brain development and behavior , 2011, Proceedings of the National Academy of Sciences.

[23]  J. Foster,et al.  Psychobiotics and the gut–brain axis: in the pursuit of happiness , 2015, Neuropsychiatric disease and treatment.

[24]  T. Dinan,et al.  The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. , 2014, Advances in experimental medicine and biology.

[25]  J. Turner,et al.  Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression. , 2009, Gastroenterology.

[26]  G. Boeckxstaens,et al.  Neuron-macrophage crosstalk in the intestine: a “microglia” perspective , 2015, Front. Cell. Neurosci..

[27]  Sylvia Daunert,et al.  Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis , 2017, Journal of cellular physiology.

[28]  J. Quevedo,et al.  Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. , 2017, Journal of affective disorders.

[29]  S. Thompson,et al.  An excitatory synapse hypothesis of depression , 2015, Trends in Neurosciences.

[30]  Luis Pedro Coelho,et al.  Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients , 2017, Genome Medicine.

[31]  Richard J Smeyne,et al.  Bacterial Peptidoglycan Traverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior , 2016, Cell host & microbe.

[32]  P. Sternberg,et al.  A comparison of experience-dependent locomotory behaviors and biogenic amine neurons in nematode relatives of Caenorhabditis elegans , 2010, BMC Neuroscience.

[33]  Jeffrey H. Kordower,et al.  Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease , 2011, PloS one.

[34]  H. Malkki Parkinson disease: Could gut microbiota influence severity of Parkinson disease? , 2017, Nature Reviews Neurology.

[35]  G. Stefano,et al.  Dopaminergic agents: influence on serotonin in the molluscan nervous system. , 1976, Science.

[36]  Wenjie Xie,et al.  Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease , 2001, The Journal of Neuroscience.

[37]  V. Pachnis,et al.  The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System , 2016, Gastroenterology.

[38]  R. Dobbs,et al.  Association of circulating TNF‐α and IL‐6 with ageing and parkinsonism , 1999 .

[39]  T. Borody,et al.  Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study , 2017, Microbiome.

[40]  T. Dinan,et al.  Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome , 2017, Neuropsychopharmacology.

[41]  M. Muqit,et al.  PINK1 and Parkin: emerging themes in mitochondrial homeostasis. , 2017, Current opinion in cell biology.

[42]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[43]  Daniel J. Chandler,et al.  Noradrenergic Modulation of Cognition in Health and Disease , 2017, Neural plasticity.

[44]  M. Thangaraju,et al.  Homeostatic PPARα Signaling Limits Inflammatory Responses to Commensal Microbiota in the Intestine , 2016, The Journal of Immunology.

[45]  J. Kong,et al.  Transcutaneous Vagus Nerve Stimulation: A Promising Method for Treatment of Autism Spectrum Disorders , 2017, Front. Neurosci..

[46]  D. Haller,et al.  Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer , 2018, Front. Immunol..

[47]  Rustem F. Ismagilov,et al.  Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis , 2015, Cell.

[48]  J. Hoffman,et al.  Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets , 2013, Nature Reviews Gastroenterology &Hepatology.

[49]  N. Van Rooijen,et al.  Ulcerative colitis exacerbates lipopolysaccharide‐induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease , 2010, Journal of neurochemistry.

[50]  Eric Gouaux,et al.  Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters , 2005, Nature.

[51]  G. Stefano,et al.  Microglia in invertebrate ganglia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Dinan,et al.  Collective unconscious: how gut microbes shape human behavior. , 2015, Journal of psychiatric research.

[53]  E. Nam,et al.  Optimization of Transcutaneous Vagus Nerve Stimulation Using Functional MRI , 2017, Neuromodulation : journal of the International Neuromodulation Society.

[54]  V. Napolioni,et al.  Urinary p-cresol in autism spectrum disorder. , 2013, Neurotoxicology and teratology.

[55]  F. Özoğul,et al.  Production of biogenic amines by Morganella morganii, Klebsiella pneumoniae and Hafnia alvei using a rapid HPLC method , 2004 .

[56]  E. Tobe Mitochondrial dysfunction, oxidative stress, and major depressive disorder , 2013, Neuropsychiatric disease and treatment.

[57]  Sara Omenetti,et al.  The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome , 2015, Front. Immunol..

[58]  K. Helke,et al.  Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease , 2017, Brain Stimulation.

[59]  H. Chuang,et al.  Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice , 2016, Behavioural Brain Research.

[60]  T. Dinan,et al.  The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus , 2018, European Neuropsychopharmacology.

[61]  I. Korona-Głowniak,et al.  The Association of Chronic Hepatitis C with Respiratory Microbiota Disturbance on the Basis of Decreased Haemophilus Spp. Colonization , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[62]  C. Conway,et al.  Sustained remission in patients with treatment-resistant depression receiving vagal nerve stimulation: A case series , 2017, Brain Stimulation.

[63]  G. Fricchione,et al.  The immune-neuro-link and the macrophage: Postcardiotomy delirium, HIV-associated dementia and psychiatry , 1994, Progress in Neurobiology.

[64]  N. Spencer,et al.  The Diverse Metabolic Roles of Peripheral Serotonin. , 2017, Endocrinology.

[65]  P. Deyn,et al.  Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story , 2017, Neurochemistry International.

[66]  Dean P. Jones,et al.  Redox dynamics of manganese as a mitochondrial life-death switch. , 2017, Biochemical and biophysical research communications.

[67]  K. Dujardin,et al.  Neurobiological correlates of emotional processing in Parkinson's disease: A systematic review of experimental studies. , 2017, Journal of psychosomatic research.

[68]  R. Kream,et al.  Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (Review). , 2007, International journal of molecular medicine.

[69]  C. Duyckaerts,et al.  The second brain and Parkinson’s disease , 2009, The European journal of neuroscience.

[70]  P. Trosvik,et al.  Linking Spatial Structure and Community-Level Biotic Interactions through Cooccurrence and Time Series Modeling of the Human Intestinal Microbiota , 2017, mSystems.

[71]  S. Finegold,et al.  Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children , 2004, Applied and Environmental Microbiology.

[72]  R. Kream,et al.  Mitochondrial DNA heteroplasmy in human health and disease , 2016, Biomedical reports.

[73]  R. Kream,et al.  Dopamine, Morphine, and Nitric Oxide: An Evolutionary Signaling Triad , 2009, CNS neuroscience & therapeutics.

[74]  B. Bonaz,et al.  Brain-gut-microbiota axis in Parkinson's disease. , 2015, World journal of gastroenterology.

[75]  P. Blain,et al.  Mitochondrial Dysfunction in Parkinson's Disease , 2011, Parkinson's disease.

[76]  T. Weir,et al.  Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. , 2015, Cell host & microbe.

[77]  E. Pekkonen,et al.  More than constipation – bowel symptoms in Parkinson's disease and their connection to gut microbiota , 2017, European journal of neurology.

[78]  R. Dobbs,et al.  Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. , 1999, Acta neurologica Scandinavica.

[79]  R. Milev,et al.  The effects of probiotics on depressive symptoms in humans: a systematic review , 2017, Annals of General Psychiatry.

[80]  J. Galligan,et al.  Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. , 2012, Gastroenterology.

[81]  G. Rizzo,et al.  Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.

[82]  Kevin D Young,et al.  Indole production by the tryptophanase TnaA in Escherichia coli is determined by the amount of exogenous tryptophan. , 2013, Microbiology.

[83]  Helen Tremlett,et al.  The gut microbiome in human neurological disease: A review , 2017, Annals of neurology.

[84]  R. Blakely,et al.  A dialogue between the immune system and brain, spoken in the language of serotonin. , 2013, ACS chemical neuroscience.

[85]  A. Ivanov Structure and regulation of intestinal epithelial tight junctions: current concepts and unanswered questions. , 2012, Advances in experimental medicine and biology.

[86]  H. Braak,et al.  Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.

[87]  V. A. Shishov,et al.  Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12 , 2009, Applied Biochemistry and Microbiology.

[88]  R. Milev,et al.  Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review , 2017, Annals of General Psychiatry.

[89]  R. Kream,et al.  Evolutionary Perspective on Microglial/Neuronal Coupling with Special Relevance to Psychiatric Illnesses , 2015 .

[90]  F. Cardarelli,et al.  Expanding the phenotype associated with FOXG1 mutations and in vivo FoxG1 chromatin‐binding dynamics , 2012, Clinical genetics.

[91]  E. Pennacchietti,et al.  Glutamate decarboxylase‐dependent acid resistance in orally acquired bacteria: function, distribution and biomedical implications of the gadBC operon , 2012, Molecular microbiology.

[92]  J. Sonnenburg,et al.  Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[93]  Alan Frazer,et al.  Vagal Nerve Stimulation for Treatment-Resistant Depression , 2017, Neurotherapeutics.

[94]  T. Dinan,et al.  Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. , 2016, Journal of psychiatric research.

[95]  M. Gerstein,et al.  FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders , 2015, Cell.

[96]  J. Tack,et al.  REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders , 2007 .

[97]  S. Mazmanian,et al.  The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut. , 2017, Immunity.

[98]  P. Brundin,et al.  Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis , 2015, Neurobiology of Disease.

[99]  Metazoan innovation: from aromatic amino acids to extracellular signaling , 2013, Amino Acids.

[100]  V. V. Roshchina,et al.  Evolutionary Considerations of Neurotransmitters in Microbial, Plant, and Animal Cells , 2010 .

[101]  H. Krum,et al.  Attenuation of microglial and neuronal activation in the brain by ICV minocycline following myocardial infarction , 2014, Autonomic Neuroscience.

[102]  J. Beatty,et al.  Genetic analysis of a bacterial genetic exchange element: the gene transfer agent of Rhodobacter capsulatus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[103]  J. Lewis,et al.  Diet, the human gut microbiota, and IBD. , 2013, Anaerobe.

[104]  K. Fassbender,et al.  Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. , 2016, Parkinsonism & related disorders.

[105]  M. Rugge,et al.  Antibiotic‐induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice , 2017, British journal of pharmacology.

[106]  M. Andresen,et al.  Cervical vagus nerve stimulation augments spontaneous discharge in second- and higher-order sensory neurons in the rat nucleus of the solitary tract. , 2017, American journal of physiology. Heart and circulatory physiology.

[107]  J Licinio,et al.  Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism , 2016, Molecular Psychiatry.

[108]  T. R. Licht,et al.  Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class , 2015, PloS one.

[109]  B. Stecher,et al.  CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis , 2017, Nature Communications.

[110]  T. Dinan,et al.  Serotonin, tryptophan metabolism and the brain-gut-microbiome axis , 2015, Behavioural Brain Research.